Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin continuous infusion versus intermittent infusion for methicillin-resistant staphylococcal pneumonia
ChiCTR-TRC-11001289Phase 4Completed
- Sponsor
- Third Hospital of Changsha
- Start
- Feb 2008
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in staphylococcal pneumonia, sponsored by Third Hospital of Changsha. Started Feb 2008; status: completed.
02
Drugs
vancomycin
03
Conditions
staphylococcal pneumonia
Beyond the preview
Go deeper on ChiCTR-TRC-11001289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001289.